Funds and prices
Overview
The fund generally invests in all equities of UK large-cap companies included in the FTSE® 100 Index. The relative weightings of the companies correspond to their weightings in the index.
The investment objective is to replicate the price and return performance of the FTSE® 100 Index net of fees. The stock exchange price may differ from the net asset value.
The fund is passively managed.
Benefits
Clients benefit from the flexibility of an exchange-traded investment.
Provides access to the performance of the index with a single transaction.
Optimised risk/return profile thanks to a broad diversification across a range of sectors.
The fund offers a high degree of transparency and cost efficiency.
UCITS compliant fund.
Risks
Features
Product category |
ÃÛ¶¹ÊÓƵ Exchange Traded Funds
ÃÛ¶¹ÊÓƵ ETF SICAV |
Product domicile |
Luxembourg
|
Portfolio management |
ÃÛ¶¹ÊÓƵ Asset Management (UK) Ltd., London
|
Fund management |
ÃÛ¶¹ÊÓƵ Fund Management (Luxembourg) S.A., Luxembourg
|
Custodian bank |
State Street Bank Luxembourg S.A.
|
Representative for products established under foreign law |
ÃÛ¶¹ÊÓƵ AG, Stockholm
|
Day of inception |
October 31, 2001
|
Currency of account |
GBP
|
Close of financial year |
December 31
|
Issue / redemption |
daily
|
Next distribution |
January
|
Maturity |
Open end
|
Management fee |
0.20% p.a.
|
Total expense ratio (TER) |
0.20% p.a.
|
Minimum investment |
n.a.
|
Reference Index / Benchmark |
FTSE 100 Total Return
|
Distribution Frequency |
twice a year
|
ISIN |
LU0136242590
|
Bloomberg Ticker |
100EUA IM, 100CHA SW, 100GBA SW, 100EUA GY, UB03 LN
|
Reuters Id |
100GBA.S, 100CHA.S
|
Performance and Prices
Percentage growth
as of April 3, 2024GBP(%) | CHF(%) | EUR(%) | USD(%) | |
YTD | ||||
1M | ||||
3M | ||||
6M | ||||
1Y | 7.31 | 8.41 | 9.90 | 9.24 |
2Y | ||||
3Y | 30.90 | 14.78 | 29.88 | 19.52 |
5Y | 27.59 | 11.18 | 26.95 | 22.35 |
ø p.a.5Y | 4.99 | 2.14 | 4.89 | 4.12 |
Current data
Net asset value | 03.04.2024 | GBP 73.27 |
High - last 12 months | 28.03.2024 | GBP 73.41 |
Low - last 12 months | 21.08.2023 | GBP 66.81 |
Last distribution | 07.02.2024 | GBP 1.18 |
Total product assets in mn | 03.04.2024 | GBP 64.96 |
Constituents | 29.02.2024 | 104.00 |
Structures
By the 10 largest equity positions (in %, as of February 29, 2024)
|
|
Shell | 8.49 |
AstraZeneca | 7.71 |
HSBC Hldgs | 6.26 |
Unilever | 5.07 |
BP | 4.02 |
GSK | 3.50 |
RELX | 3.43 |
Diageo | 3.42 |
Rio Tinto | 2.89 |
British American Tobacco | 2.73 |
Fees
Distributions
Date of distribution
|
Pay date
|
Cps no.
|
Currency
|
Distribution
|
|||||||
08.08.2023 | 11.08.2023 | - | GBP | 1.43 | n.a. | 01.02.2024 | 07.02.2024 | - | GBP | 1.18 | n.a. |
Authorisations
Literature
Document type
|
Document Language
|
Prospectus |
|
Key Information Document |
|
Past performance |
|
Previous performance scenario |
|
Document type
|
Document Language
|
Solvency II Reporting Q1 2023 |
|
Solvency II Reporting Q2 2023 |
|
Solvency II Reporting Q3 2023 |
|
Solvency II Reporting Q4 2023 |
|
Document type
|
Document Language
|
Annual report |
|
Semi-annual report |
|